Related Experiment Video

Updated: Apr 26, 2026

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction
05:26

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction

Published on: May 28, 2019

11.1K

What Is the Appropriate Duration of High-Dose Atorvastatin Therapy Post-Acute Coronary Syndrome?

Pavel Goriacko, Matthew Andersen, Roman Fazylov

    Journal of Pharmacy Practice
    |August 10, 2014
    PubMed

    Insights

    High-intensity atorvastatin therapy after acute coronary syndrome (ACS) should continue for at least five years. This duration maximizes the reduction in coronary events, despite potential adverse reactions leading to discontinuation.

    Area of Science:

    • Cardiology
    • Pharmacology

    Background:

    • Acute coronary syndrome (ACS) necessitates effective long-term management.
    • High-intensity statin therapy is a cornerstone in post-ACS care.

    Purpose of the Study:

    • To determine the optimal duration of high-intensity atorvastatin therapy following an acute coronary syndrome (ACS).

    Main Methods:

    • A comprehensive literature review was performed using the MEDLINE database (1966-October 2013).
    • Search terms included “atorvastatin OR statins AND myocardial infarction OR acute coronary syndromes.”
    • Four major clinical trials evaluating atorvastatin 80 mg daily post-ACS were identified and analyzed.

    Main Results:

    • High-dose atorvastatin (80 mg daily) significantly reduced coronary events post-ACS.
    • The benefits of high-dose atorvastatin were sustained for a minimum of 5 years.
    • Higher rates of drug discontinuation and dose reductions due to adverse reactions were observed.

    Conclusions:

    • High-intensity atorvastatin therapy should be maintained for at least 5 years after an ACS.
    • While effective in reducing events, careful monitoring for adverse reactions is crucial.
    • The sustained benefit supports long-term use in appropriate patients.
    Abstract

    More Related Videos

    Acetylcholine Re-Challenge After Intracoronary Nitroglycerine Administration07:59

    Acetylcholine Re-Challenge After Intracoronary Nitroglycerine Administration

    Published on: April 4, 2022

    1.5K
    Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation28:13

    Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

    Published on: February 26, 2013

    34.6K

    Related Concept Videos

    Acute Coronary Syndrome IV: Interprofessional Care01:28

    Acute Coronary Syndrome IV: Interprofessional Care

    IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
    519
    Atherosclerosis III: Management01:26

    Atherosclerosis III: Management

    Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
    701
    Coronary Artery Disease V: Interprofessional Care01:27

    Coronary Artery Disease V: Interprofessional Care

    Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
    442
    Acute Coronary Syndrome V: Nursing Management01:26

    Acute Coronary Syndrome V: Nursing Management

    Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...
    610
    Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

    Lipid-Lowering Drugs: Statins and Miscellaneous Agents

    Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
    1.7K
    Acute Coronary Syndrome I: Introduction01:30

    Acute Coronary Syndrome I: Introduction

    Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
    2.0K